Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Aix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Trends Immunol. 2020 May;41(5):436-452. doi: 10.1016/j.it.2020.03.002. Epub 2020 Mar 26.
The innate lymphoid cell (ILC) family consists of natural killer (NK) cells, helper-like lymphoid cells (ILC1s, ILC2s, and ILC3s), and lymphoid tissue inducer (LTi) cells. Helper-like ILCs are considered the innate counterpart of T-helper cells because of similarities in their cytokine output and expression of key transcription factors. ILCs provide and regulate innate immune functions before the development of adaptive immunity. They are involved in host defense against pathogens, inflammation, tissue repair, and metabolic homeostasis. However, they can also be involved in inflammatory disorders and carcinogenesis. In this review, we summarize the latest research on ILC development and plasticity in humans and mice, focusing on the pathogenic role of helper-like ILCs in inflammatory disorders, such as asthma, Crohn's disease (CD), and rheumatoid arthritis (RA).
天然淋巴细胞 (ILC) 家族包括自然杀伤 (NK) 细胞、辅助样淋巴细胞 (ILC1、ILC2 和 ILC3) 和淋巴组织诱导 (LTi) 细胞。辅助样 ILC 因其细胞因子产生和关键转录因子表达的相似性,被认为是 T 辅助细胞的先天对应物。ILC 在适应性免疫发展之前提供和调节先天免疫功能。它们参与宿主对病原体、炎症、组织修复和代谢稳态的防御。然而,它们也可能参与炎症性疾病和癌症发生。在这篇综述中,我们总结了人类和小鼠中 ILC 发育和可塑性的最新研究,重点介绍了辅助样 ILC 在炎症性疾病(如哮喘、克罗恩病 (CD) 和类风湿关节炎 (RA))中的致病作用。